Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The hemp extract significantly increased hair regrowth in both men and women without any side effects.

Extracorporeal shock waves significantly improve hair growth in women with female pattern hair loss.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

The editorial concludes that the field of hair loss treatment has become more scientific and that effective treatments are important for self-esteem and job prospects.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Successful hair transplant surgery depends on careful patient selection, proper surgical plan and technique, and attentive aftercare.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Menopause can cause skin issues, and seeing a dermatologist helps.

Men and women have different hairline restoration needs, with natural design being more complex for women, and hairline changes being important for transgender individuals' transitions.

A man with rare Lichen Planopilaris lost body hair, not scalp hair, and treatment stopped itching but didn't regrow hair.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Doctors should thoroughly inform hair transplant patients about the procedure, risks, and costs to prevent dissatisfaction and legal issues.

A dermatoscope is important for evaluating hair transplants and managing patient expectations.

FPHL affects hair density and diameter, causing visible hair loss in older women.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Hair follicle regeneration possible, more research needed.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

The conclusion is that teeth, hair, and claws have similar stem cell niches, which are important for growth and repair, and more research is needed on their regulation and potential markers.

Antiandrogen therapy helps treat genetic hair loss.

Nutrients like vitamins, copper, zinc, and amino acids are crucial for healthy hair and wool growth.

Women's hair grows faster and thicker than men's, but hair growth slows for both genders with pattern hair loss.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.